Pulse Biosciences (PLSE) Trading Up 23.4%

Shares of Pulse Biosciences Inc (NASDAQ:PLSE) were up 23.4% during mid-day trading on Thursday . The company traded as high as $19.66 and last traded at $19.15. Approximately 500,098 shares traded hands during trading, an increase of 300% from the average daily volume of 125,083 shares. The stock had previously closed at $15.52.

A number of analysts have recently issued reports on PLSE shares. BidaskClub cut Pulse Biosciences from a “sell” rating to a “strong sell” rating in a research report on Wednesday, February 14th. ValuEngine upgraded Pulse Biosciences from a “sell” rating to a “hold” rating in a research report on Sunday, December 31st.

How to Become a New Pot Stock Millionaire

Pulse Biosciences (NASDAQ:PLSE) last released its quarterly earnings data on Friday, March 16th. The company reported ($0.53) earnings per share (EPS) for the quarter.

A number of large investors have recently made changes to their positions in PLSE. Ladenburg Thalmann Financial Services Inc. bought a new stake in Pulse Biosciences in the fourth quarter valued at $158,000. The Manufacturers Life Insurance Company grew its position in Pulse Biosciences by 1,785.0% in the fourth quarter. The Manufacturers Life Insurance Company now owns 7,295 shares of the company’s stock valued at $172,000 after acquiring an additional 6,908 shares during the period. Fore Capital LLC bought a new stake in Pulse Biosciences in the fourth quarter valued at $236,000. Brown Advisory Inc. bought a new stake in Pulse Biosciences in the fourth quarter valued at $248,000. Finally, Alliancebernstein L.P. bought a new stake in Pulse Biosciences in the fourth quarter valued at $248,000. Hedge funds and other institutional investors own 10.85% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Pulse Biosciences (PLSE) Trading Up 23.4%” was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3338398/pulse-biosciences-plse-trading-up-23-4.html.

About Pulse Biosciences

Pulse Biosciences, Inc, formerly Electroblate, Inc, is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue.

Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Somewhat Favorable News Coverage Somewhat Unlikely to Affect UDR  Stock Price
Somewhat Favorable News Coverage Somewhat Unlikely to Affect UDR Stock Price
Duke Realty  Receives Coverage Optimism Rating of 0.25
Duke Realty Receives Coverage Optimism Rating of 0.25
Everi  Lowered to “Sell” at Zacks Investment Research
Everi Lowered to “Sell” at Zacks Investment Research
Investors Buy The Coca-Cola  on Weakness
Investors Buy The Coca-Cola on Weakness
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Jazz Pharmaceuticals  Stock Price
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Jazz Pharmaceuticals Stock Price
Traders Buy Shares of United Parcel Service  on Weakness
Traders Buy Shares of United Parcel Service on Weakness


© 2006-2018 Ticker Report. Google+.